ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

FDA Oncologic Drugs Advisory Committee: Trials In A Small Indication Tell Big Story About Pitfalls of Delaying Progression

April 15, 2011

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

June 27, 2003

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983

NCAB Approves Funding for New Construction At Georgetown, Yale

June 3, 1977